Is IVUS Guided PCI a Common Technique?

We all know the benefits of ultravascular ultrasound (IVUS) in the development of percutaneous coronary intervention, such as more accurate vessel measurement, improved stent expansion and apposition, and complication identification. This is why the use of IVUS is a class IIa recommendation in AHA and ESC guidelines. 

¿Es frecuente el uso de IVUS para guiar la ATC?

The aim of this retrospective study was to assess the use of IVUS in complex PCI and to compare mortality and the need for target vessel revascularization in patients with IVUS guided PCI vs unguided PCI. 

Complex lesions included bifurcations, chronic total occlusion, unprotected left main, long lesions >33 mm, instent restenosis, severe calcifications, multivessel PCI, and multiple stenting.  

Primary end point was mortality and target vessel revascularization at 2 years. 

In 44305 patients receiving complex lesion PCI, 13.9% of procedures were guided by IVUS: 33% of these were on left main lesions, 15% multiple stenting, 14% multivessel PCI, and 14% long lesions. The use of IVUS guided PCI grew from 13% in 2014 to 16% in 2018.

Read also: High Risk of Bleeding after PCI: More Evidence for Short DAPT.

Patients in the IVUS guided arm more often presented ejection fraction >50%, with left main and proximal descending artery compromise, and the use of drug eluting stents, while also less frequently presented recent MI, right coronary artery compromise and lesions in small and tortuous vessels. 

As regards results, IVUS guided PCI showed significantly lower mortality and less treated vessel revascularization at followup. 

Conclusion

The use of IVUS in complex lesion PCI occurs in low numbers despite the considerable evidence in support of its use. Treating these lesions with IVUS showed reduced morality and target vessel revascularization at midterm compared against PCI without IVUS guidance.  

Dr. Andrés Rodríguez
Member of the Editorial Board of SOLACI.org.

Original Title: Percutaneous Coronary Intervention With and Without Intravascular Ultrasound for Patients With Complex Lesions: Utilization, Mortality, and Target Vessel Revascularization.

Reference: Edward L. Hannan et al Circ Cardiovasc Interv. 2022;15:e011687.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...